Summary
Recombinant human granulocyte colony-stimulating factor (rhG-CSF) has been used mainly for treatment of chemotherapy-induced neutropenia. The reported side effects were of minor importance. We describe a case of long-term treatment with rhG-CSF, in which we observed enhanced bone remodeling.
Similar content being viewed by others
References
Bonilla MA et al. (1989) Effects to recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 320: 1574–1580
Crawford J, Ozer H, Johnson D, et al. (1990) Granulocyte colony-stimulating factor: prevention of chemotherapy-induced febrile neutropenia (FN) in patients with small cell lung cancer (SCLC). A randomized double-blind placebo-controlled trial. Proc Am Soc Clin Oncol 9: 229
Demetri GD, Griffin JD (1991) Granulocyte colony-stimulating factor and its receptor. Blood 77: 2791–2808
Hammond WP et al. (1989) Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N Engl J Med 320: 1306–1311
Lee MY, Fukanaga R, Lee TJ, Lottsfeldt JL, Nagata S (1991) Bone modulation in sustained hematopoietic stimulation in mice. Blood 77: 2135–2141
Merz WA, Schenk RK (1970) Quantitative structural analysis of cancellous bone. Acta Anat 75: 54–66
Merz WA, Schenk RK (1970) A quantitative histological study on bone formation of human cancellous bone. Acta Anat 76: 1–15
Morstyn G, Campbell L, Souza LM, Alton NK, Keech J, Green M, Sheridan W, Metcalf D, Fox R (1988) Effect of granulocyte colony-stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1: 667–672
Pootrakul P, Hungsprenges S, Fucharoen S, et al. (1981) Relation between erythropoiesis and bone metabolism in thalassemia. N Engl J Med 304: 1470–1473
Weite K et al. (1990) Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 75: 1056–1063
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Woermann, U.J., Schenk, R., Zimmermann, A. et al. Increased bone metabolism in a patient undergoing long-term rhG-CSF treatment for idiopathic acquired neutropenia. Ann Hematol 66, 267–268 (1993). https://doi.org/10.1007/BF01738479
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01738479